Wave Life Sciences WVE
NASDAQ WVE
$3.64 -0.03 (-0.82%)
At close: Sep 29, 2026 · 4:00 PM EDT

Wave Life Sciences (WVE) Share-based Compensation (2015 - 2016)

Updated

Wave Life Sciences' Share-based Compensation was $1.27 million in Q2 2016, up 96.6% from $646,000 a year earlier and up 46.7% from the prior quarter.

Analysis

Wave Life Sciences (WVE) Share-based Compensation (2015 - 2016) Analysis & Trends

On a trailing twelve-month basis, Wave Life Sciences' Share-based Compensation was $3.67 million through Jun 30, 2016; for FY2015, it was $4.02 million.

  • The Q2 2016 figure marks the highest quarterly Share-based Compensation since Q1 2015.
  • Per Business Quant data, WVE's Share-based Compensation in the three quarters before Q2 2016 was $866,000 (Q1 2016), $814,000 (Q4 2015) and $718,000 (Q3 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Wave Life Sciences 709.33 Mn -1.00 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 1.27 Mn
Mar 31, 2016 866,000.00
Dec 31, 2015 814,000.00
Sep 30, 2015 718,000.00
Jun 30, 2015 646,000.00
Mar 31, 2015 1.85 Mn
API Access

Wave Life Sciences Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=WVE&period=max&api_key=YOUR_API_KEY